Correlation Between Pacira BioSciences, and Takeda Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pacira BioSciences, and Takeda Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pacira BioSciences, and Takeda Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pacira BioSciences, and Takeda Pharmaceutical Co, you can compare the effects of market volatilities on Pacira BioSciences, and Takeda Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pacira BioSciences, with a short position of Takeda Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pacira BioSciences, and Takeda Pharmaceutical.

Diversification Opportunities for Pacira BioSciences, and Takeda Pharmaceutical

-0.71
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Pacira and Takeda is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Pacira BioSciences, and Takeda Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Takeda Pharmaceutical and Pacira BioSciences, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pacira BioSciences, are associated (or correlated) with Takeda Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Takeda Pharmaceutical has no effect on the direction of Pacira BioSciences, i.e., Pacira BioSciences, and Takeda Pharmaceutical go up and down completely randomly.

Pair Corralation between Pacira BioSciences, and Takeda Pharmaceutical

Given the investment horizon of 90 days Pacira BioSciences, is expected to under-perform the Takeda Pharmaceutical. In addition to that, Pacira BioSciences, is 3.06 times more volatile than Takeda Pharmaceutical Co. It trades about -0.03 of its total potential returns per unit of risk. Takeda Pharmaceutical Co is currently generating about 0.0 per unit of volatility. If you would invest  1,418  in Takeda Pharmaceutical Co on September 4, 2024 and sell it today you would lose (32.00) from holding Takeda Pharmaceutical Co or give up 2.26% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Pacira BioSciences,  vs.  Takeda Pharmaceutical Co

 Performance 
       Timeline  
Pacira BioSciences, 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Pacira BioSciences, are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Pacira BioSciences, showed solid returns over the last few months and may actually be approaching a breakup point.
Takeda Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Takeda Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Takeda Pharmaceutical is not utilizing all of its potentials. The newest stock price mess, may contribute to short-term losses for the institutional investors.

Pacira BioSciences, and Takeda Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pacira BioSciences, and Takeda Pharmaceutical

The main advantage of trading using opposite Pacira BioSciences, and Takeda Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pacira BioSciences, position performs unexpectedly, Takeda Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Takeda Pharmaceutical will offset losses from the drop in Takeda Pharmaceutical's long position.
The idea behind Pacira BioSciences, and Takeda Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stocks Directory
Find actively traded stocks across global markets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios